Profile for Five Prime Therapeutics, Inc. (FPRX)
« Back to company indexFPRX Chatter Timeline
Stock Ticker for FPRX
Most Active Tweeters for FPRX
| User | Tweets |
|---|---|
| @OlympiaReport | 6 |
| @registrarjourn | 6 |
| @ZolmaxNews | 6 |
| @ThisLincolnian | 6 |
| @WatchlistN | 6 |
Recent Tweets for FPRX
 |
@OlympiaReport Analysts’ Recent Ratings Updates for Five Prime Therapeutics $FPRX https://t.co/h4uGT3yyu9 May 23rd 2018, 9:05am |
 |
@ledgerzette Analysts’ Recent Ratings Updates for Five Prime Therapeutics $FPRX https://t.co/DSlYmdLcgf May 23rd 2018, 6:05am |
 |
@ZolmaxNews Five Prime Therapeutics $FPRX Upgraded to Buy by BidaskClub https://t.co/mAgpZLF0VN May 23rd 2018, 1:05am |
 |
@SolarMelt $FPRX Up in a bad market. Got a few presentations/abstracts/posters coming up at ASCO in two-to-three weeks. https://t.co/x7SmwjYZF5 May 22nd 2018, 8:05pm |
 |
@gsi_momo_alerts Momentum Mover Alert: $FPRX https://t.co/xgj7zTIZTr May 22nd 2018, 3:05pm |
|
@SolarMelt $FPRX Got a little Giddyup today too. https://t.co/p8x8gxiGNU May 22nd 2018, 2:05pm |
 |
@WeekHerald Five Prime Therapeutics $FPRX Raised to Buy at Zacks Investment Research https://t.co/zEqt3CtNPQ May 22nd 2018, 7:05am |
 |
@registrarjourn Five Prime Therapeutics $FPRX Raised to Buy at BidaskClub https://t.co/SuKb73jYYP May 22nd 2018, 6:05am |
|
@ZolmaxNews Five Prime Therapeutics $FPRX Raised to Buy at Zacks Investment Research https://t.co/SSklse8qT1 May 22nd 2018, 2:05am |
 |
@WatchlistN Five Prime Therapeutics $FPRX Raised to Buy at BidaskClub https://t.co/iypGYo44DD May 22nd 2018, 2:05am |
 |
@dakotafinancial Five Prime Therapeutics $FPRX Raised to Buy at BidaskClub https://t.co/MwMIatQk7B May 22nd 2018, 2:05am |
 |
@Cdanno RT @FivePrime_FPRX: We at $FPRX are creating the insights that drive #ClinicalScience and #DrugDiscovery. https://t.co/nBrHNUbATj May 21st 2018, 8:05pm |
 |
@FivePrime_FPRX We at $FPRX are creating the insights that drive #ClinicalScience and #DrugDiscovery. https://t.co/nBrHNUbATj May 21st 2018, 12:05pm |
|
@WatchlistN Five Prime Therapeutics $FPRX Stock Rating Lowered by Zacks Investment Research https://t.co/NJmdxZD6a6 May 21st 2018, 8:05am |
 |
@ThisLincolnian Five Prime Therapeutics $FPRX Lifted to Buy at Zacks Investment Research https://t.co/AnYRaaGgfK May 21st 2018, 8:05am |
|
@WeekHerald Five Prime Therapeutics $FPRX Stock Rating Lowered by Zacks Investment Research https://t.co/TcqiSZA5M1 May 21st 2018, 7:05am |
|
@ledgerzette BidaskClub Upgrades Five Prime Therapeutics $FPRX to “Buy” https://t.co/79NlTFfYUA May 21st 2018, 6:05am |
|
@ZolmaxNews Five Prime Therapeutics $FPRX Receives New Coverage from Analysts at Wedbush https://t.co/j57Yij9msa May 21st 2018, 5:05am |
 |
@dispatchtribune Five Prime Therapeutics $FPRX Lifted to Buy at Zacks Investment Research https://t.co/u6uwnb2D5R May 21st 2018, 5:05am |
|
@OlympiaReport Five Prime Therapeutics $FPRX Stock Rating Upgraded by Zacks Investment Research https://t.co/fJtfClIHQz May 21st 2018, 5:05am |
|
@OlympiaReport BidaskClub Upgrades Five Prime Therapeutics $FPRX to “Buy” https://t.co/RIQNXNxRi1 May 21st 2018, 2:05am |
 |
@TranscriptDaily Five Prime Therapeutics Inc $FPRX Receives Average Rating of “Buy” from Brokerages https://t.co/3WWFHAYXPX May 20th 2018, 11:05pm |
|
@registrarjourn Analysts Set Five Prime Therapeutics Inc $FPRX Price Target at $37.67 https://t.co/VTGdNHHCyW May 20th 2018, 11:05pm |
|
@OlympiaReport Zacks Investment Research Lowers Five Prime Therapeutics $FPRX to Hold https://t.co/ZouooqyPZF May 20th 2018, 11:05am |
|
@WeekHerald Five Prime Therapeutics $FPRX Upgraded to Buy at BidaskClub https://t.co/HP74Bhx2LJ May 20th 2018, 9:05am |
 |
@TheMarketsDaily Five Prime Therapeutics $FPRX Upgraded to Buy at BidaskClub https://t.co/XPYp220rSU May 20th 2018, 9:05am |
|
@WatchlistN Five Prime Therapeutics $FPRX Earns Neutral Rating from Analysts at Wedbush https://t.co/hNfj9X6iQ9 May 20th 2018, 9:05am |
 |
@surveyist RT @SolarMelt: $FPRX FivePrime Very Active At ASCO - JUN 2018 Presentation/Abstracts/Posters - P1/2 - Cabiralizumab (PVNS) - P2 - Cabiraliz… May 19th 2018, 6:05pm |
|
@SolarMelt $FPRX Looks even better on a weekly chart. I've got six buy signals here, including a Double Bottom and Parabolic S… https://t.co/544T2fT8LT May 19th 2018, 3:05pm |
|
@SolarMelt $FPRX The chart looks pretty good too. https://t.co/3QywA1tHxb May 19th 2018, 2:05pm |
|
@SolarMelt $FPRX FivePrime Very Active At ASCO - JUN 2018 Presentation/Abstracts/Posters - P1/2 - Cabiralizumab (PVNS) - P2 -… https://t.co/CVAfvFCblx May 19th 2018, 2:05pm |
 |
@TickerReport Five Prime Therapeutics $FPRX Stock Rating Upgraded by Zacks Investment Research https://t.co/ACYyDxhmAw May 19th 2018, 1:05pm |
 |
@ConsumerFeed Five Prime Therapeutics $FPRX Upgraded to “Buy” by Zacks Investment Research https://t.co/07cjJE5lP8 May 19th 2018, 1:05pm |
 |
@AmericanBanking Five Prime Therapeutics $FPRX Upgraded to “Buy” by BidaskClub https://t.co/wsgX261h4L #stocks May 19th 2018, 1:05pm |
 |
@dailypoliticaln Five Prime Therapeutics $FPRX Now Covered by Wedbush https://t.co/skRbQkJgwd May 19th 2018, 11:05am |
|
@TickerReport Five Prime Therapeutics $FPRX Now Covered by Wedbush https://t.co/LiPtjvaUFg May 19th 2018, 11:05am |
|
@registrarjourn Five Prime Therapeutics $FPRX Upgraded to “Buy” by Zacks Investment Research https://t.co/GX2uj3mebN May 19th 2018, 11:05am |
|
@ConsumerFeed Five Prime Therapeutics $FPRX Downgraded by Zacks Investment Research to “Hold” https://t.co/BkqTpH6j1l May 19th 2018, 5:05am |
|
@dailypoliticaln Five Prime Therapeutics $FPRX Raised to Buy at BidaskClub https://t.co/HOpEu86AuX May 19th 2018, 4:05am |
|
@TickerReport Five Prime Therapeutics $FPRX Raised to Buy at BidaskClub https://t.co/pya1wiMYgD May 19th 2018, 4:05am |
|
@AmericanBanking Five Prime Therapeutics $FPRX Stock Rating Upgraded by Zacks Investment Research https://t.co/0mSvlwOGNq #stocks May 18th 2018, 10:05pm |
|
@WatchlistN Five Prime Therapeutics $FPRX Rating Increased to Buy at Zacks Investment Research https://t.co/JMfVimC5Y7 May 18th 2018, 10:05pm |
|
@ZolmaxNews Five Prime Therapeutics $FPRX Downgraded by Zacks Investment Research https://t.co/h9TRU5dmep May 18th 2018, 1:05pm |
|
@dailypoliticaln Five Prime Therapeutics $FPRX Downgraded to Hold at Zacks Investment Research https://t.co/x7HwaEKBwk May 18th 2018, 1:05pm |
|
@ConsumerFeed Five Prime Therapeutics $FPRX Coverage Initiated by Analysts at Wedbush https://t.co/KFZXaMGjTu May 18th 2018, 1:05pm |
|
@ThisLincolnian Five Prime Therapeutics $FPRX Coverage Initiated by Analysts at Wedbush https://t.co/UYgAlc3lCD May 18th 2018, 1:05pm |
 |
@stocknewsdotcom $FPRX Wedbush initiates as a Neutral https://t.co/1YbHlPsiAI May 18th 2018, 8:05am |
 |
@tradnews_ RT @AlertTrade: UP/DOWNGRADES ? $FPRX: Wedbush starts at Neutral https://t.co/Xcl5xoxFds via ? https://t.co/VS8RO1bzXJ May 18th 2018, 8:05am |
 |
@AlertTrade UP/DOWNGRADES ? $FPRX: Wedbush starts at Neutral https://t.co/Xcl5xoxFds via ? https://t.co/VS8RO1bzXJ May 18th 2018, 8:05am |
 |
@WarrenofWallSt Traditional fundamentals don't apply to Biotechs like #FivePrimeTherapeutics $FPRX https://t.co/ngo1kcFMVt https://t.co/4Zy15t7Sfi May 18th 2018, 1:05am |
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.